期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 63, 期 18, 页码 10135-10157出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.9b02038
关键词
-
资金
- National Natural Science Foundation of China [81573281, 81872728, 81973207]
- Natural Science Foundation [BK20191411]
- Double First-Class Initiative Innovation team project of China Pharmaceutical University [CPU2018GF11, CPU2018GY34]
- Jiangsu Qinglan Project
p62/SQSTM1, encoded by gene SQSTM1, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein involved in Nrf2 activation to resist oxidative stress. Multiple domains of p62 interact with several essential pathways implicated in cell differentiation and proliferation, placing p62 at a significant position to mediate cell survival and apoptosis. The p62 protein has been suggested as a potential target in recent years, since its abnormal expression or SQSTM1 gene mutation is tightly associated with various diseases including cancer such as hepatocellular carcinoma and prostate cancer, neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis, atherosclerosis, and Paget's disease of bone. In this review, we will discuss the relationship between p62 and these diseases, and we attempt to put forward novel methods for current diagnosis or therapy by regulating the p62 expression level.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据